Literature DB >> 31948304

Do lung cancer patients require routine anticoagulation treatment? A meta-analysis.

Mengying Zhang1, Shuxie Wu2, Chengping Hu1.   

Abstract

Entities:  

Keywords:  Lung cancer; anticoagulation; prognosis; risk factor; thromboprophylaxis; thrombosis

Year:  2020        PMID： 31948304      PMCID： PMC7113707          DOI： 10.1177/0300060519896919

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  37 in total

Review 1.  Novel drug development opportunities for heparin.

Authors:  Rebecca Lever; Clive P Page
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

2.  Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.

Authors:  Sylvia K Haas; Mathias Freund; David Heigener; Lothar Heilmann; Bettina Kemkes-Matthes; Georg-Friedrich von Tempelhoff; Nima Melzer; Ajay K Kakkar
Journal:  Clin Appl Thromb Hemost       Date:  2012-01-23       Impact factor: 2.389

Review 3.  Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer.

Authors:  Anna Falanga; Francesca Schieppati; Domenico Russo
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

4.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Authors:  Helen K Chew; Theodore Wun; Danielle Harvey; Hong Zhou; Richard H White
Journal:  Arch Intern Med       Date:  2006-02-27

5.  Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis.

Authors:  Ali Amirkhosravi; Shaker A Mousa; Mildred Amaya; Todd Meyer; Monica Davila; Theresa Robson; John L Francis
Journal:  Methods Mol Biol       Date:  2010

6.  Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.

Authors:  Taxiarchis V Kourelis; Ewa M Wysokinska; Yi Wang; Ping Yang; Aaron S Mansfield; Alfonso J Tafur
Journal:  Lung Cancer       Date:  2014-10-12       Impact factor: 5.705

7.  ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events.

Authors:  Terry L Ng; Derek E Smith; Rao Mushtaq; Tejas Patil; Anastasios Dimou; Shuo Yang; Qian Liu; Xuefei Li; Caicun Zhou; Robert T Jones; Megan M Tu; Flora Yan; I Alex Bowman; Stephen V Liu; Siera Newkirk; Joshua Bauml; Robert C Doebele; Dara L Aisner; Dexiang Gao; Shengxiang Ren; D Ross Camidge
Journal:  J Thorac Oncol       Date:  2018-12-10       Impact factor: 15.609

8.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Authors:  Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Mandalà; Luigi Cavanna; Sandro Barni; Roberto Labianca; Franco Buzzi; Giovanni Scambia; Rodolfo Passalacqua; Sergio Ricci; Giampietro Gasparini; Vito Lorusso; Erminio Bonizzoni; Maurizio Tonato
Journal:  Lancet Oncol       Date:  2009-08-31       Impact factor: 41.316

9.  The incidence and predictors of thromboembolic events in patients with lung cancer.

Authors:  Bohdan Kadlec; Jana Skrickova; Zdenek Merta; Ladislav Dusek; Jiri Jarkovsky
Journal:  ScientificWorldJournal       Date:  2014-01-20

10.  Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.

Authors:  Joanna Rupa-Matysek; Marta Lembicz; Eliza Katarzyna Rogowska; Lidia Gil; Mieczysław Komarnicki; Halina Batura-Gabryel
Journal:  Med Oncol       Date:  2018-04-03       Impact factor: 3.064
View more
  3 in total

Review 1.  Coagulation parameters in lung cancer patients: A systematic review and meta-analysis.

Authors:  Biruk Bayleyegn; Tiruneh Adane; Solomon Getawa; Melak Aynalem; Zemen Demelash Kifle
Journal:  J Clin Lab Anal       Date:  2022-06-19       Impact factor: 3.124

2.  Thrombin-mediated vasculogenic mimicry: important lessons to improve anticoagulant therapy of selected cancer patients.

Authors:  C Arnold Spek
Journal:  Signal Transduct Target Ther       Date:  2020-10-30

Review 3.  Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies.

Authors:  Manar Mosaad; Mohamed Hassan Elnaem; Ejaz Cheema; Ismail Ibrahim; Jamalludin Ab Rahman; Ahlam Naila Kori; How Soon Hin
Journal:  Int J Gen Med       Date:  2021-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.